These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28199992)

  • 1. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers.
    Karras JR; Schrock MS; Batar B; Huebner K
    Cytogenet Genome Res; 2016; 150(3-4):208-216. PubMed ID: 28199992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
    Saldivar JC; Park D
    Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
    Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
    PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
    Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common fragile genes and digestive tract cancers.
    Kuroki T; Tajima Y; Furui J; Kanematsu T
    Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large common fragile site genes and cancer.
    Smith DI; McAvoy S; Zhu Y; Perez DS
    Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FHIT gene product: tumor suppressor and genome "caretaker".
    Waters CE; Saldivar JC; Hosseini SA; Huebner K
    Cell Mol Life Sci; 2014 Dec; 71(23):4577-87. PubMed ID: 25283145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of FHIT and WWOX fragile genes in cancer.
    Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
    Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of
    Simón-Carrasco L; Pietrini E; López-Contreras AJ
    Cell Cycle; 2024 Jan; 23(1):92-113. PubMed ID: 38234243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular parameters of genome instability: roles of fragile genes at common fragile sites.
    Pichiorri F; Ishii H; Okumura H; Trapasso F; Wang Y; Huebner K
    J Cell Biochem; 2008 Aug; 104(5):1525-33. PubMed ID: 18393361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.